Evidence map›Paper›PMID 40209105›Full record

ArticleBrain : a journal of neurology2025

Dysregulated cortical excitability and tau phosphorylation in a β3 integrin mouse model of autism.

Carmela Vitale, Fanny Jaudon, Rafael Luján, Martina Bartolucci, Lucia Celora, Elisa Reisoli, Riccardo Ruggeri, Andrea Petretto, Agnes Thalhammer, Lorenzo A Cingolani

Abstract read
In one paragraph

Article in Brain : a journal of neurology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Article
  2. Review
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Carmela VitaleCenter for Synaptic Neuroscience and Technology (NSYN), Fondazione Istituto Italiano di Tecnologia (IIT), Genoa 16132, Italy.
Fanny JaudonDepartment of Life Sciences, University of Trieste, Trieste 34127, Italy.
Rafael LujánSynaptic Structure Laboratory, Instituto de Biomedicina de la UCLM (IB-UCLM), Departamento de Ciencias Médicas, Facultad de Medicina, Universidad Castilla-La Mancha, Albacete 02008, Spain.
Martina BartolucciCore Facilities-Clinical Proteomics and Metabolomics, IRCCS, Istituto Giannina Gaslini, Genova 16147, Italy.
Lucia CeloraDepartment of Life Sciences, University of Trieste, Trieste 34127, Italy.
Elisa ReisoliCenter for Synaptic Neuroscience and Technology (NSYN), Fondazione Istituto Italiano di Tecnologia (IIT), Genoa 16132, Italy.
Riccardo RuggeriDepartment of Life Sciences, University of Trieste, Trieste 34127, Italy.
Andrea PetrettoCore Facilities-Clinical Proteomics and Metabolomics, IRCCS, Istituto Giannina Gaslini, Genova 16147, Italy.
Agnes ThalhammerCenter for Synaptic Neuroscience and Technology (NSYN), Fondazione Istituto Italiano di Tecnologia (IIT), Genoa 16132, Italy.
Lorenzo A CingolaniCenter for Synaptic Neuroscience and Technology (NSYN), Fondazione Istituto Italiano di Tecnologia (IIT), Genoa 16132, Italy.ORCID 0000-0001-9538-1659

Funding

Cariplo Foundation 2019-3438European Research Development Fund PID2021-125875OB-I00HORIZON EUROPE European Research Council 101099579Junta de Comunidades de Castilla-La Mancha SBPLY/21/180501/000064Ministero dell'Istruzione, dell'Università e della Ricerca J53D23011040006Ministero dell'Istruzione, dell'Università e della Ricerca MCIN/AEI/10.13039/501100011033
6 · The paper itself

Abstract

Autism spectrum disorder is a complex neurodevelopmental disease characterized by altered cortical network excitability. Recent genetic studies have identified deep layer V cortical pyramidal neurons in the frontal cortex as central to autism pathophysiology, yet the cortical circuits, plasticity mechanisms and molecular signalling pathways involved remain poorly understood. Layer V pyramidal neurons consist of two main types with distinct functional roles: intratelencephalic neurons, which respond to low-frequency stimulation and project within the cortex and striatum, and pyramidal tract neurons, which are tuned to theta-frequency inputs and convey information to subcortical structures. Determining which of these two neuron types is more critical to autism pathophysiology and whether disruptions in their synaptic connectivity or intrinsic excitability contribute to autism-related dysfunctions would significantly advance our understanding of the disorder. Integrins, a family of cell adhesion molecules, are vital for neuronal function. The gene encoding β3 integrin (ITGB3) is genetically linked to autism spectrum disorder, with rare mutations identified in affected individuals, while Itgb3 knockout mice exhibit autism-like behaviours, including impaired social memory and increased grooming. However, it remains unclear why loss of β3 integrin is associated with autism spectrum disorder, how it disrupts cortical circuits, and which plasticity mechanisms and molecular pathways are involved. Here, we demonstrate that β3 integrin selectively regulates the excitability of pyramidal tract neurons in the medial prefrontal cortex. Using electrophysiology, proteomics and molecular approaches, we show that β3 integrin regulates the gain, adaptation and precision of action potential discharge by controlling the surface expression of Ca2+-activated SK2 channels. Genetic ablation of Itgb3 impaired intrinsic excitability and SK2 channel function in pyramidal tract neurons, with no effects in intratelencephalic neurons. Furthermore, we identified Tau, a protein traditionally linked to neurodegenerative diseases, as part of the SK2 channel interactome. Proteomic analyses revealed altered protein kinase A-dependent phosphorylation of Tau in Itgb3 knockout mice, while protein kinase A inhibition restored SK2 channel currents, thereby connecting phosphorylation changes to excitability deficits. Our findings expand the current mechanistic framework linking signalling pathway dysfunctions to cortical excitability deficits, highlighting the dysregulation of pyramidal tract neuron excitability as a core feature of autism pathophysiology and demonstrating the involvement of β3 integrin, SK2 channels, Tau and PKA in this process. Because pyramidal tract neurons serve as final integrators of cortical computations before relaying information outside the cortex, their impaired excitability may disrupt communication with subcortical targets, contributing to the complex pathophysiology of autism spectrum disorder.

Indexed as

Autism Spectrum DisorderAutistic DisorderCerebral CortexCortical ExcitabilityIntegrin beta3tau ProteinsAnimalsDisease Models, AnimalMaleMiceMice, Inbred C57BLMice, KnockoutPhosphorylationPyramidal CellsIntegrin beta3tau Proteinsintrinsic excitabilitylayer V pyramidal neuronsmedial prefrontal cortexPKASK2 channelsspike frequency adaptation

Identifiers

PMID40209105
PMCPMC12493053

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.